# Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke

Study · id `cardio:ct-nct06900725` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06900725](<https://clinicaltrials.gov/study/NCT06900725>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06900725

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT06900725. Randomized; no masking; primary purpose prevention. Start 2025-04-01 (anticipated); primary completion 2030-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT06900725, source copy `cardio:ctgov-nct06900725-2025-04-02`, retrieved 2026-10-26)
- Planned start: 2025-04-01 (anticipated) (ClinicalTrials.gov record NCT06900725, source copy `cardio:ctgov-nct06900725-2025-04-02`, retrieved 2026-10-26)
- Primary completion: 2030-12-31 (anticipated) (ClinicalTrials.gov record NCT06900725, source copy `cardio:ctgov-nct06900725-2025-04-02`, retrieved 2026-10-26)
- Completion: 2030-12-31 (anticipated) (ClinicalTrials.gov record NCT06900725, source copy `cardio:ctgov-nct06900725-2025-04-02`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT06900725, source copy `cardio:ctgov-nct06900725-2025-04-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06900725-2025-04-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke
- Acronym: LEAVE-Stroke
- Condition: Elderly
- Condition: Atrial Fibrillation (AF)
- Condition: Ischemic Stroke
- Intervention (Drug): edoxaban
- Intervention (Drug): Edoxaban 30 mg
- Lead sponsor: National Taiwan University Hospital
- Lead sponsor class: OTHER
- Collaborator: National Taiwan University Hospital, Yun-Lin Branch
- Collaborator class: OTHER
- Collaborator: National Taiwan University Hospital Hsin-Chu Branch
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Edoxaban (`cardio:edoxaban`)
- Registry lists this organization as the lead sponsor: National Taiwan University Hospital (`cardio:org-national-taiwan-university-hospital`)

## Provenance

Content hash: 945d0f98c2744f1725d9cb87a3f336c4fba8a5517cc7192d3bd4a1d1f8772dc0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
